Biotech · Private company
Nerviano Medical Sciences
Track this companyFree. Adds Nerviano Medical Sciences to your Dealase workspace and tells you when its record changes.
Clinical trials74 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- NMS-01940153EPhase 2 · Unresectable Hepatocellular Carcinoma (HCC)ClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03305293Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03305293Phase 1 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03305293Phase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03305293Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03597812Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03597812Phase 1 · Relapsed/Refractory Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- NMS-03597812 + dexamethasonePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 1 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- TopotecanPhase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Study of NMS-03305293 in Adult Patients With Relapsed Ovarian CancerPHASE1 · RECRUITING · started May 13, 2026ClinicalTrials.gov NCT06930755 · fetched Nov 12, 2026
- Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung CancerPHASE1 · RECRUITING · started Aug 15, 2025ClinicalTrials.gov NCT06931626 · fetched Nov 12, 2026
- Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid LeukemiaPHASE1 · RECRUITING · started Oct 16, 2024ClinicalTrials.gov NCT06549790 · fetched Nov 12, 2026
- Ph I Study in Adult Patients With Relapsed or Refractory Multiple MyelomaPHASE1 · TERMINATED · started Sep 9, 2022ClinicalTrials.gov NCT05027594 · fetched Nov 12, 2026
- Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent GlioblastomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 1, 2021ClinicalTrials.gov NCT04910022 · fetched Nov 12, 2026
- Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyPHASE1_PHASE2 · TERMINATED · started Nov 13, 2020ClinicalTrials.gov NCT05630937 · fetched Nov 12, 2026
- Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid TumorsPHASE1 · TERMINATED · started Nov 25, 2019ClinicalTrials.gov NCT04182516 · fetched Nov 12, 2026